nach oben

Inflammation

Erschienen in:

01.06.2008

C-Reactive Protein is Linked to Lower Cognitive Performance in Overweight and Obese Women

verfasst von: V. Sweat, V. Starr, H. Bruehl, A. Arentoft, A. Tirsi, E. Javier, A. Convit

Erschienen in: Inflammation | Ausgabe 3/2008

Einloggen, um Zugang zu erhalten

Abstract

Our objective was to ascertain the nature of the associations between C-reactive protein (CRP) and cognition, and to examine how they are affected by gender and obesity. We evaluated 62 females and 63 males between 42 and 82 years of age. There were 20 lean females with a body mass index (BMI) of <25 kg/m² and 42 overweight or obese females, with BMIs ≥25 kg/m². There were 14 lean males and 49 with BMIs ≥25 kg/m². CRP was associated with lower scores on cognitive tests of frontal lobe function among females and these associations were driven by the overweight/obese female group. In these data no associations between CRP and cognition were found among males. Obesity-associated inflammation is much more prominent in females and it appears to be associated with cognitive dysfunction, particularly of frontal lobe tasks.

Lee, W.-Y., J.-S. Park, S.-Y. Noh, E.-J. Rhee, K.-C. Sung, B.-S. Kim, J.-H. Kang, S.-W. Kim, M.-H. Lee, and J.-R. Park. 2004. C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report. Int. J. Cardiol. 97:101–106.PubMedCrossRef

Wang, Z., and W. E. Hoy. 2007. C-reactive protein and the risk of developing type 2 diabetes in Aboriginal Australians. Diabetes Res. Clin. Pract. 76:37–43.PubMedCrossRef

Han, T., C. Gonzalez-Villalpando, N. Sattar, M. Lean, K. Williams, and S. M. Haffner. 2007. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 25(11):2016–2021.CrossRef

Pearson, T. A., G. A. Mensah, R. W. Alexander, J. L. Anderson, R. O. Cannon III, M. Criqui, Y. Y. Fadl, S. P. Fortmann, Y. Hong, G. L. Myers, N. Rifai, S. C. Smith Jr., K. Taubert, R. P. Tracy, and F. Vinicor. 2003. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107(3):499–511 (Jan).PubMedCrossRef

Kushner, I., D. Rzewnicki, and D. Samols. 2006. What does minor elevation of C-reactive protein signify? Am. J. Med. 119:166.e17–166.e28.CrossRef

Swanson, S. J., M. M. McPeek, and R. F. Mortensen. 1989. Characteristics of the binding of human C-reactive protein (CRP) to laminin. J. Cell Biochem. 40(1):121–132 (May).PubMedCrossRef

Pepys, M. B., and M. L. Baltz. 1983. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv. Immunol. 34:141–212.PubMedCrossRef

Haffner, S. M. 2006. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am. J. Cardiol. 97(2, Supplement 1):3–11 (Jan).CrossRef

Parikh, N. I., M. J. Pencina, T. J. Wang, K. J. Lanier, C. S. Fox, R. B. D’Agostino, and R. S. Vasan. 2007. Increasing trends in incidence of overweight and obesity over 5 decades. Am. J. Med. 120(3):242–250 (Mar).PubMedCrossRef

10.

Ye, X., Z. Yu, H. Li, O. H. Franco, Y. Liu, and X. Lin. 2007. Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J. Am. Coll. Cardiol. 49(17):1798–1805 (May).PubMedCrossRef

11.

Florez, H., S. Castillo-Florez, A. Mendez, P. Casanova-Romero, C. Larreal-Urdaneta, D. Lee, and R. Goldberg. 2006. C-reactive protein is elevated in obese patients with the metabolic syndrome. Diabetes Res. Clin. Pract. 71(1):92–100 (Jan).PubMedCrossRef

12.

Wasir, J. S., A. Misra, N. K. Vikram, R. M. Pandey, and K. Luthra. 2007. C-reactive protein, obesity, and insulin resistance in postmenopausal women in urban slums of North India. Diabetes and Metabolic Syndrome: Clinical Research and Reviews 1(2):83–89 (Jun).CrossRef

13.

Thorand, B., J. Baumert, A. Doring, C. Herder, H. Kolb, W. Rathmann, G. Giani, and W. Koenig. 2006. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 184(1):216–224 (Jan).PubMedCrossRef

14.

Rexrode, K. M., A. Pradhan, J. E. Manson, J. E. Buring, and P. M. Ridker. 2003. Relationship of total and abdominal adiposity with CRP and IL-6 in women. Ann. Epidemiol. 13(10):674–682 (Nov).PubMedCrossRef

15.

Lear, S., M. Chen, C. L. Birmingham, and J. J. Frohlich. 2003. The relationship between simple anthropometric indices and C-reactive protein: ethnic and gender differences. Metabolism 52(12):1542–1546.PubMedCrossRef

16.

Khera, A., D. McGuire, S. Murphy, H. Stanek, S. Das, W. Vongpatanasin, F. Wians, S. Grundy, and J. de Lemos. 2005. Race and gender differences in C-reactive protein levels. J. Am. Coll. Cardiol. 46(3):464–469.PubMedCrossRef

17.

Pieroni, L., J. P. Bastard, A. Piton, L. Kalil, B. Hainique, and C. Jardel. 2003. Interpretation of circulating C-reactive protein levels in adults: body mass index and gender are a must. Diabetes Metab. 29:133–138.PubMedCrossRef

18.

Kraus, V. B., T. V. Stabler, G. Luta, J. B. Renner, A. D. Dragomir, and J. M. Jordan. 2007. Interpretation of serum C-reactive protein (CRP) levels for cardiovascular disease risk is complicated by race, pulmonary disease, body mass index, gender, and osteoarthritis. Osteoarth. Cartil. 15(8):966–971 (Aug).CrossRef

19.

Lakoski, S., M. Cushman, M. Criqui, T. Rundek, R. Blumenthal, R. B. D’Agostino, and D. Herrington. 2006. Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort. Am. Heart J. 152(3):593–598.PubMedCrossRef

20.

Kluft, C. 2002. HRT effects on inflammatory markers: is chronic inflammation a contra-indication for HRT? Int. Congr. Ser. 1229:103–108.CrossRef

21.

Abdullah, S. M., A. Khera, D. Leonard, S. R. Das, R. M. Canham, S. A. Kamath, G. L. Vega, S. M. Grundy, D. K. McGuire, and J. A. de Lemos. 2007. Sex differences in the association between leptin and CRP: results from the Dallas Heart Study. Atherosclerosis 195(2):404–410 (Dec).PubMedCrossRef

22.

Ferrannini, E., A. Natali, P. Bell, P. Cavallo-Perin, N. Lalic, and G. Mingrone. 1997. Insulin resistance and hypersecretion in obesity. J. Clin. Invest. 100(5):1166–1173 (Sep).PubMedCrossRef

23.

Smith, D. O., and D. LeRoith. 2004. Insulin resistance syndrome, pre-diabetes, and the prevention of type 2 diabetes mellitus. Clin. Cornerstone 6(2):7–13.PubMedCrossRef

24.

Biessels, G.-J., E. ter Braak, D. Erkelens, and R. Hijman. 2001. Cognitive function in patients with type 2 diabetes mellitus. Neurosci. Res. Commun. 28(1):11–22.CrossRef

25.

Akisaki, T., T. Sakurai, T. Takata, H. Umegaki, A. Araki, S. Mizuno, S. Tanaka, Y. Ohashi, A. Iguchi, K. Yokono, and H. Ito. 2006. Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese elderly diabetes intervention trial (J-EDIT). Diabetes Metab. Res. Rev. 22(5):376–384.PubMedCrossRef

26.

Strachan, M., I. Deary, F. Ewing, and B. Frier. 1997. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 20(3):438–445.PubMedCrossRef

27.

Vanhanen, M., K. Koivisto, L. Karjalainen, E. L. Helkala, M. Laakso, H. Soininen, and P. Riekkinen, Sr. 1997. Risk for non-insulin-dependent diabetes in the normoglycaemic elderly is associated with impaired cognitive function. NeuroReport. 8(6):1527–1530.PubMedCrossRef

28.

Convit, A. 2005. Links between cognitive impairment in insulin resistance: an explanatory model. Neurobiol. Aging 26(1, Supplement 1):31–35 (Dec).PubMedCrossRef

29.

Gold, S. M., I. Dziobek, V. Sweat, A. Tirsi, K. Rogers, H. Bruehl, W. Tsui, S. Richardson, E. Javier, and A. Convit. 2007. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia 50(4):711–719.PubMedCrossRef

30.

Convit, A., O. T. Wolf, C. Tarshish, and M. J. de Leon. 2003. Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly. Proc. Natl. Acad. Sci. U. S. A. 100(4):2019–2022.PubMedCrossRef

31.

Gunstad, J., R. H. Paul, R. A. Cohen, D. F. Tate, M. B. Spitznagel, and E. Gordon. 2007. Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Compr. Psychiatry 48(1):57–61.PubMedCrossRef

32.

Weisell, R. C. 2002. Body mass index as an indicator of obesity. Asia Pac. J. Clin. Nutr. 11(Suppl 8):S681–S684.CrossRef

33.

Jeong, S. K., H. S. Nam, M. H. Son, E. J. Son, and K. H. Cho. 2005. Interactive effect of obesity indexes on cognition. Dement. Geriatr. Cogn. Disord. 19(2–3):91–96.PubMedCrossRef

34.

Elias, M. F., P. K. Elias, L. M. Sullivan, P. A. Wolf, and R. B. D’Agostino. 2005. Obesity, diabetes and cognitive deficit: the Framingham Heart Study. Neurobiol. Aging 26(1, Supplement 1):11–16 (Dec).PubMedCrossRef

35.

Cournot, M., J. C. Marquie, D. Ansiau, C. Martinaud, H. Fonds, J. Ferrieres, and J. B. Ruidavets. 2006. Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurol. 67(7):1208–1214 (Oct).CrossRef

36.

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285(19):2486–2497 (May).

37.

Komulainen, P., T. A. Lakka, M. Kivipelto, M. Hassinen, E. L. Helkala, I. Haapala, A. Nissinen, and R. Rauramaa. 2007. Metabolic syndrome and cognitive function: a population-based follow-up study in elderly women. Dement. Geriatr. Cogn. Disord. 23(1):29–34.PubMedCrossRef

38.

Yaffe, K., A. Kanaya, K. Lindquist, E. M. Simonsick, T. Harris, R. I. Shorr, F. A. Tylavsky, and A. B. Newman. 2004. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292(18):2237–2242 (Nov).PubMedCrossRef

39.

Dik, M. G., C. Jonker, H. C. Comijs, D. J. Deeg, A. Kok, K. Yaffe, and B. W. Penninx. 2007. Contribution of metabolic syndrome components to cognition in older persons. Diabetes Care 30:2655–2660 (Jun).PubMedCrossRef

40.

Kuo, H. K., C. J. Yen, C. H. Chang, C. K. Kuo, J. H. Chen, and F. Sorond. 2005. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis. Lancet Neurol. 4(6):371–380 (Jun).PubMedCrossRef

41.

Bruehl, H., M. Rueger, I. Dziobek, V. Sweat, A. Tirsi, E. Javier, A. Arentoft, O. T. Wolf, and A. Convit. 2007. Hypothalamic–pituitary–adrenal axis dysregulation and memory impairments in Type 2 diabetes. J. Clin. Endocrinol. Metab. 92(7):2439–2445 (Jul).PubMedCrossRef

42.

Executive Summary of the Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. J. Am. Diet Assoc. 98(10):1178–1191 (Oct).

43.

Raz, N., K. M. Rodrigue, and J. D. Acker. 2003. Hypertension and the brain: vulnerability of the prefrontal regions and executive functions. Behav. Neurosci. 117(6):1169–1180 (Dec).PubMedCrossRef

44.

Lezak, M. D. 1995. Neuropsychological Assessment. 3rd ed. Oxford University Press, New York.

45.

Hamilton, M. 1960. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23:56–62.PubMed

46.

Ansell, B., K. Watson, R. Weiss, and G. Fonarow. 2003. hsCRP and HDL Effects of Statins Trial (CHEST): rapid effect of statin therapy on C-reactive protein and high-density lipoprotein levels. Heart Dis. 5:2–7.PubMedCrossRef

47.

Hanefeld, M., N. Marx, A. Pfutzner, W. Baurecht, G. Lubben, E. Karagiannis, U. Stier, and T. Forst. 2007. Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study. J. Am. Coll. Cardiol. 49(3):290–297 (Jan).PubMedCrossRef

48.

Kinlay, S. 2007. Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein. J. Am. Coll. Cardiol. 49(20):2003–2009.PubMedCrossRef

49.

Kritchevsky, S. B., M. Cesari, and M. Pahor. 2005. Inflammatory markers and cardiovascular health in older adults. Cardiovasc. Res. 66(2):265–275 (May).PubMedCrossRef

50.

Neisser, U., G. Boodoo, T. J. Bouchard, A. W. Boykin, N. Brody, S. J. Ceci, D. F. Halpern, J. C. Loehlin, R. Perloff, R. J. Sternberg, and S. Urbina. 1996. Intelligence: knowns and unknowns. Am. Psychol. 51(2):77–101 (Feb).CrossRef

51.

Barzilai, N., G. Atzmon, C. A. Derby, J. M. Bauman, and R. B. Lipton. 2006. A genotype of exceptional longevity is associated with preservation of cognitive function. Neurol. 67:2170–2175.CrossRef

52.

Ramlawi, B., J. L. Rudolph, S. Mieno, J. Feng, M. Boodhwani, K. Khabbaz, S. E. Levkoff, E. R. Marcantonio, C. Bianchi, and F. W. Sellke. 2006. C-reactive protein and inflammatory response associated to neurocognitive decline following cardiac surgery. Surgery 140(2):221–226 (Aug).PubMedCrossRef

53.

Mathew, J. P., M. V. Podgoreanu, H. P. Grocott, W. D. White, R. W. Morris, M. Stafford-Smith, G. B. Mackensen, C. S. Rinder, J. A. Blumenthal, D. A. Schwinn, and M. F. Newman. 2007. Genetic variants in P-selectin and C-reactive protein influence susceptibility to cognitive decline after cardiac surgery. J. Am. Coll. Cardiol. 49(19):1934–1942 (May).PubMedCrossRef

54.

de Luca, C., and J. M. Olefsky. 2006. Stressed out about obesity and insulin resistance. Nat. Med. 12(1):41–42 (Jan).PubMedCrossRef

55.

Johnson, J. L., C. A. Slentz, B. D. Duscha, G. P. Samsa, J. S. McCartney, J. A. Houmard, and W. E. Kraus. 2004. Gender and racial differences in lipoprotein subclass distributions: the STRRIDE study. Atherosclerosis 176(2):371–377 (Oct).PubMedCrossRef

56.

Abdullah, S. M., A. Khera, D. Leonard, S. R. Das, R. M. Canham, S. A. Kamath, G. L. Vega, S. M. Grundy, D. K. McGuire, and J. A. de LemosSex differences in the association between leptin and CRP: results from the Dallas Heart Study. Atherosclerosis 195(2):404–410.PubMedCrossRef

57.

Molina, M. J., A. M. Mayor, A. E. Franco, C. A. Morell, M. A. Lopez, and L. M. Vila. 2007. Prevalence of systemic lupus erythematosus and associated comorbidities in Puerto Rico. J. Clin. Rheumatol. 13(4):202–204 (Aug).PubMedCrossRef

58.

Racial/ethnic differences in the prevalence and impact of doctor-diagnosed arthritis—United States, 2002. MMWR Morb Mortal Wkly Rep. 54(5):119–123 (Feb).

59.

Linares, L. F., J. J. Gomez-Reino, P. E. Carreira, L. Morillas, and I. Ibero. 1986. C-reactive protein (CRP) levels in systemic lupus erythematosus (SLE). Clin. Rheumatol. 5(1):66–69 (Jan).PubMedCrossRef

60.

Popkova, T. V., A. N. Khelkovskaia, E. S. Mach, E. N. Aleksandrova, A. A. Novikov, D. S. Novikova, and E. L. Nasonov. 2007. Cardiovascular diseases in rheumatoid arthritis. Ter. Arkh. 79(5):9–14.PubMed

61.

Urowitz, M. B., and D. D. Gladman. 2007. Atherosclerosis and lupus—the SLICC study. Lupus. 16(12):925–928.PubMedCrossRef

62.

Assous, N., E. Touze, C. Meune, A. Kahan, and Y. Allanore. 2007. Cardiovascular disease in rheumatoid arthritis: single-center hospital-based cohort study in France. Jt. Bone Spine 74(1):66–72 (Jan).CrossRef

63.

Shucard, J. L., J. J. Gaines, J. Ambrus Jr., and D. W. Shucard. 2007. C-reactive protein and cognitive deficits in systemic lupus erythematosus. Cogn. Behav. Neurol. 20(1):31–37 (Mar).PubMedCrossRef

64.

Nandula, S. R., S. Amarnath, A. Molinolo, B. C. Bandyopadhyay, B. Hall, C. M. Goldsmith, C. Zheng, J. Larsson, T. Sreenath, W. Chen, I. S. Ambudkar, S. Karlsson, B. J. Baum, and A. B. Kulkarni. 2007. Female mice are more susceptible to developing inflammatory disorders due to impaired transforming growth factor beta signaling in salivary glands. Arthritis Rheum. 56(6):1798–1805 (Jun).PubMedCrossRef

65.

Pradhan, A. D., J. E. Manson, J. E. Rossouw, D. S. Siscovick, C. P. Mouton, N. Rifai, R. B. Wallace, R. D. Jackson, M. B. Pettinger, and P. M. Ridker. 2002. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women’s Health Initiative observational study. JAMA 288(8):980–987 (Aug).PubMedCrossRef

66.

Singh, U., S. Devaraj, J. Vasquez-Vivar, and I. Jialal. 2007. C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. J. Mol. Cell Cardiol. 43(6):780–791 (Dec).PubMedCrossRef

67.

Jialal, I., S. Devaraj, and S. K. Venugopal. 2004. C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 44(1):6–11 (Jul).PubMedCrossRef

68.

Verma, S., C. H. Wang, S. H. Li, A. S. Dumont, P. W. Fedak, M. V. Badiwala, B. Dhillon, R. D. Weisel, R. K. Li, D. A. Mickle, and D. J. Stewart. 2002. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106(8):913–919 (Aug).PubMedCrossRef

69.

Schmidt, R., C. Enzinger, S. Ropele, H. Schmidt, and F. Fazekas. 2006. Subcortical vascular cognitive impairment: Similarities and differences with multiple sclerosis. J. Neurol. Sci. 245(1–2):3–7 (Jun).PubMedCrossRef

70.

Gold, S. M., I. Dziobek, K. Rogers, A. Bayoumy, P. F. McHugh, and A. Convit. 2005. Hypertension and hypothalamo–pituitary–adrenal axis hyperactivity affect frontal lobe integrity. J. Clin. Endocrinol. Metab. 90(6):3262–3267 (Jun).PubMedCrossRef

71.

Raz, N., K. M. Rodrigue, and J. D. Acker. 2003. Hypertension and the brain: vulnerability of the prefrontal regions and executive functions. Behav. Neurosci. 117(6):1169–1180 (Dec).PubMedCrossRef

72.

van Dijk, E. J., N. D. Prins, S. E. Vermeer, H. A. Vrooman, A. Hofman, P. J. Koudstaal, and M. M. B. Breteler. 2005. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 112(6):900–905 (Aug).PubMedCrossRef

Titel: C-Reactive Protein is Linked to Lower Cognitive Performance in Overweight and Obese Women
verfasst von: V. Sweat
V. Starr
H. Bruehl
A. Arentoft
A. Tirsi
E. Javier
A. Convit
Publikationsdatum: 01.06.2008
Verlag: Springer US
Erschienen in: Inflammation / Ausgabe 3/2008
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-008-9065-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

C-Reactive Protein is Linked to Lower Cognitive Performance in Overweight and Obese Women

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2008

IL-17 Producing γδ T Cells are Required for a Controlled Inflammatory Response after Bleomycin-induced Lung Injury

Spermine and Endothelial Damage During Endotoxemia

Low Level Laser Therapy (LLLT) Decreases Pulmonary Microvascular Leakage, Neutrophil Influx and IL-1β Levels in Airway and Lung from Rat Subjected to LPS-Induced Inflammation

Serum Pro-hepcidin Levels in Rheumatoid Arthritis and Systemic Lupus Erythematosus

Anti-inflammatory Effects of Ethanol Extract from Kummerowia striata (Thunb.) Schindl on LPS-Stimulated RAW 264.7 Cell

SOCS-1 Inhibits TNF-α-Induced Cardiomyocyte Apoptosis via ERK1/2 Pathway Activation

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin